Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

rTM reprograms macrophages via the HIF-1α/METTL3/PFKM axis to protect mice against sepsis.

Cellular and molecular life sciences : CMLS·2024
Same author

ScRNA-seq and bulk RNA-seq identified NUPR1 as novel biomarkers related to CD4 + T cells infiltration for abdominal aortic aneurysm.

Molecular biology reports·2024
Same author

Targeting fibroblast activation protein with chimeric antigen receptor macrophages.

Biochemical pharmacology·2024
Same author

Reactive arthritis in connective tissue diseases; one should be vigilant for joint tuberculosis.

Tropical doctor·2024
Same author

A Nomogram for Predicting Cancer-Associated Venous Thromboembolism in Hospitalized Patients Receiving Chemoradiotherapy for Cancer.

Cancer control : journal of the Moffitt Cancer Center·2024
Same author

Automatic detection of epileptic seizure based on one dimensional cascaded convolutional autoencoder with adaptive window-thresholding.

Journal of neural engineering·2024

相关实验视频

Updated: Jul 17, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

27.8K

肠道微生物群和慢性阻塞性肺病之间的因果关系:双向的双样本孟德尔随机化研究

Wen-Jia Li1, Chen Yao2, Lu Han1

  • 1Department of Pulmonary and Critical Care Medicine, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen City, People's Republic of China.

International journal of chronic obstructive pulmonary disease
|September 9, 2024
PubMed
概括

这项研究揭示了11种肠道细菌物种与慢性阻塞性肺病 (COPD) 有因果关系. 某些细菌可以预防COPD,而其他细菌,如Holdemanella和Marvinbryantia,会增加风险,为新疗法提供点.

关键词:
慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.协会 协会 协会 协会 协会双向MR是指向两个方向的.这是因果关系的原因.我们的肠道微生物群.

更多相关视频

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
07:38

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome

Published on: August 3, 2021

2.3K
Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

3.9K

相关实验视频

Last Updated: Jul 17, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

27.8K
Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
07:38

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome

Published on: August 3, 2021

2.3K
Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

3.9K

科学领域:

  • 微生物组研究的研究.
  • 肺部医学 肺部医学
  • 遗传学 是一个遗传学.

背景情况:

  • 肠道微生物群在慢性阻塞性肺病 (COPD) 中的作用越来越多地被研究.
  • 肠道微生物群和COPD之间的因果关系尚不清楚.
  • 这项研究调查了肠道微生物群是否影响COPD的发展.

研究的目的:

  • 确定肠道微生物群和COPD之间的因果关系.
  • 为了识别与COPD风险或保护相关的特定肠道细菌.
  • 为COPD的临床诊断和治疗提供见解.

主要方法:

  • 在全基因组关联研究 (GWAS) 数据上利用双向门德尔随机化 (MR) 分析.
  • 采用了MR-Egger回归,逆方差加权 (IVW) 和加权中位数方法.
  • 进行异质性和敏感性分析,以确保结果的可靠性.

主要成果:

  • 确定了11种与COPD相关的肠道微生物群物种.
  • 细菌菌,科林塞拉和其他物种显示出对COPD的保护作用.
  • 霍尔德曼尼拉菌和马文布兰蒂亚菌被确定为风险因素,分别增加了COPD风险的1.14倍和1.15倍.
  • 反向MR分析没有发现COPD与肠道微生物群的因果关系.

结论:

  • 确定了11种肠道微生物群和COPD之间的因果关系.
  • 这些发现为新型COPD疗法提供了潜在的目标.
  • 需要进一步的临床研究来确认机制和治疗潜力.